Insider Transactions in Q4 2023 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2023
|
Benjamin J. Hindson |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+2.83%
|
$91,674
$11.48 P/Share
|
|
Dec 27
2023
|
Serge Saxonov Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,935
+1.71%
|
$14,935
$1.2 P/Share
|
|
Dec 14
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.12%
|
$108,000
$54.77 P/Share
|
|
Nov 24
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,723
-0.44%
|
$160,089
$43.72 P/Share
|
|
Nov 22
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,757
-0.44%
|
$161,551
$43.34 P/Share
|
|
Nov 22
2023
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
1,679
-1.7%
|
$72,197
$43.34 P/Share
|
|
Nov 22
2023
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
3,449
-1.23%
|
$148,307
$43.34 P/Share
|
|
Nov 22
2023
|
James Wilbur Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,464
-3.99%
|
$148,952
$43.34 P/Share
|
|
Nov 20
2023
|
James Wilbur Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
14,718
-14.5%
|
$618,156
$42.09 P/Share
|
|
Nov 14
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.23%
|
$78,000
$39.52 P/Share
|
|
Oct 17
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,979
-0.23%
|
$77,181
$39.51 P/Share
|
|
Oct 16
2023
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21
-0.0%
|
$819
$39.5 P/Share
|